GMED
NYSE
US
Globus Medical, Inc. Class A Common Stock
$94.44
▲ +$1.68
(+1.81%)
Vol 21K
Mkt Cap
$12.8B
P/E
23.7
ROE
12.4%
Margin
18.3%
Beta
1.06
52W
$52–$101
Wall Street Consensus
22 analysts · Apr 20264
Strong Buy
12
Buy
6
Hold
0
Sell
0
Strong Sell
72.7%
Buy Rating
Price Chart
Similar Stocks
DXCM
Dexcom Inc
P/E 35.9
$25.9B
ZBH
Zimmer Biomet Holdings, Inc
P/E 26.7
$18.8B
PODD
Insulet Corp
P/E 81.2
$20.0B
PEN
Penumbra Inc
P/E 73.4
$13.0B
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
NVST
Envista Holdings Corp
P/E 93.9
$4.4B
ABT
Abbott Laboratories
P/E 26.3
$165.2B
Earnings
Beat rate: 75.0%
Next Report
May 12, 2026
EPS Estimate: $0.94
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.94 | — | — |
| Dec 2025 | $1.17 | $1.28 | +$0.11 |
| Sep 2025 | $0.80 | $1.18 | +$0.38 |
| Jun 2025 | $0.77 | $0.86 | +$0.09 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $657.3M | $598.1M | $745.3M | $769.0M | $826.4M |
| Net Income | — | $26.5M | $75.5M | $202.8M | $119.0M | $140.6M |
Fundamentals Trend
| Metric | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 12.4% | 12.4% |
| P/E (TTM) | 22.70 | 23.74 |
| Net Margin | 18.3% | 18.3% |
| Gross Margin | 67.4% | 67.4% |
| D/E Ratio | — | — |
| Current Ratio | 4.26 | 4.26 |
Key Ratios
ROA (TTM)
10.7%
P/S (TTM)
4.34
P/B
2.6
EPS (TTM)
$3.93
CF/Share
$2.36
Rev Growth 3Y
+42.2%
52W High
$101.40
52W Low
$51.79
$51.79
52-Week Range
$101.40
Financial Health
Free Cash Flow
$202.3M
Net Debt
-$407.5M
Cash
$526.2M
Total Debt
$118.7M
As of Dec 31, 2025
How does GMED compare to Health Care peers?
Peer group: Peers · Health Care (Peers) · 10 companies
GMED valuation vs Health Care peers
P/E ratio
22.7
▼
14%
below
peers
(26.3)
vs Peers
vs Industry
Undervalued
P/S ratio
4.2
▼
16%
below
peers
(4.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.6
▼
51%
below
peers
(5.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(1.1%)
vs Peers
vs Industry
In line
GMED profitability vs Health Care peers
ROE
12.4%
▼
22%
below
peers
(15.9%)
vs Peers
vs Industry
Weak
Net margin
18.3%
▲
34%
above
peers
(13.7%)
vs Peers
vs Industry
Top tier
Gross margin
67.4%
▲
10%
above
peers
(61.3%)
vs Peers
vs Industry
Top tier
ROA
10.7%
▲
19%
above
peers
(9.0%)
vs Peers
vs Industry
Top tier
GMED financial health vs Health Care peers
D/E ratio
—
▼
0%
below
peers
(82.5)
vs Peers
vs Industry
In line
Current ratio
4.3
▲
140%
above
peers
(1.8)
vs Peers
vs Industry
Strong liquidity
Beta
1.1
▲
5%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
GMED fundamentals radar
GMED
Peer median
Industry
GMED profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
GMED vs peers: key metrics
Insider Activity
BearishBuys
0
Sells
2
$2766700
HULLER KELLY GRACE
General Counsel · Feb 25
sale
20000 shs
HULLER KELLY GRACE
General Counsel · Feb 25
conversion of exercise of derivative security
20000 shs
HULLER KELLY GRACE
General Counsel · Feb 12
sale
10000 shs
HULLER KELLY GRACE
General Counsel · Feb 12
conversion of exercise of derivative security
10000 shs
Last 90 days
Top Holders
Top 5: 26.22%Vanguard Group Inc
7.80%
$953.9M
Blackrock Inc.
7.60%
$929.9M
Janus Henderson Group PLC
5.39%
$659.6M
Invesco Ltd.
2.87%
$351.4M
State Street Corporation
2.56%
$313.2M
As of Dec 31, 2025